India to soon have larger doses of ‘Remdesivir’ for COVID-19 patients: AIIMS Director

New Delhi, June 12 (ANI): The Director of All India Institute of Medical Sciences, (AIIMS), Dr Randeep Guleria talked about the latest anti-viral drugs which are being used for treatment of COVID-19. “There are some anti-viral drugs which are being used; one of them is 'Remdesivir' that is being made by a company from United States. Data suggests that it helps to decrease hospital stay but it doesn't show benefit as far as death or mortality benefit is concerned,” said AIIMS Director. “There are Indian companies now which have got the license to make 'Remdesivir', we are hopeful that in next few weeks we’ll be able to have larger doses of this drug available,” the AIIMS Director added.